Danaher Corporation (BMV:DHR)

Market Cap	2.82T
Revenue (ttm)	486.64B
Net Income (ttm)	76.92B
Shares Out	n/a
EPS (ttm)	105.35
PE Ratio	36.70
Forward PE	25.27
Dividend	22.16 (0.59%)
Ex-Dividend Date	Jun 27, 2025

Volume	28
Average Volume	143
Open	3,747.79
Previous Close	3,900.10
Day's Range	3,747.79 - 3,747.79
52-Week Range	3,615.00 - 5,631.00
Beta	0.83
RSI	35.73
Earnings Date	Jul 22, 2025

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manuf...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1969
• Employees: 63,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: DHR

Financial Performance

In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.

Financial numbers in USD